+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Arena Pharmaceuticals Inc - logo

Arena Pharmaceuticals is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has one product on the market and several others in development. Lorcaserin is used long term for weight loss in those who are obese. It works by increasing feelings of fullness so that less food is eaten. The U.S. Food and Drug Administration (FDA) approved Lorcaserin on June 27, 2012. Arena Pharmaceuticals is headquartered in Zofingen, Switzerland.

Eosinophilic Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Esophagitis - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
From
Extended-Release Drugs Market Report 2025 - Product Thumbnail Image

Extended-Release Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Ethical Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Ethical Pharmaceuticals Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Cannabinoid Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Fecal Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Fecal Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Atopic Dermatitis - Competitive Landscape, 2023 - Product Thumbnail Image

Atopic Dermatitis - Competitive Landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
From
Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
5-HT2C Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2C Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator